General population and cancer patient norms for the functional assessment of cancer therapy-general (FACT-G)

被引:414
作者
Brucker, PS [1 ]
Yost, K [1 ]
Cashy, J [1 ]
Webster, K [1 ]
Cella, D [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, CORE, Evanston Northwestern Healthcare, Evanston, IL 60208 USA
关键词
quality of life; reference values; cancer; normative data;
D O I
10.1177/0163278705275341
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Given the number of new cancer cases diagnosed each year and the increases in survival rates, the importance of having a clinically useful health-related quality of life (HRQOL) instrument has increased. The Functional Assessment of Cancer Therapy-General (FACT-G) is one such instrument that has been used worldwide to assess HRQOL. Previously, the use of the FACT-G had been limited because of a lack of published normative data. Normative data are useful for consumers to place their results in an appropriate context by comparing their scores of individuals or group of individuals to a reference group. Here, we present normative data for the FACT-G for two reference groups: (a) a sample of the general U.S. adult population and (b) a large, heterogeneous sample of adult patients with cancer. In addition, we demonstrate various uses of the normative data.
引用
收藏
页码:192 / 211
页数:20
相关论文
共 15 条
  • [1] [Anonymous], 2005, Cancer facts and figures
  • [2] Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population
    Cella, D
    Zagari, MJ
    Vandoros, C
    Gagnon, DD
    Hurtz, HJ
    Nortier, JWR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) : 366 - 373
  • [3] Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales
    Cella, D
    Eton, DT
    Lai, JS
    Peterman, AH
    Merkel, DE
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 24 (06) : 547 - 561
  • [4] Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening
    Cella, D
    Hahn, EA
    Dineen, K
    [J]. QUALITY OF LIFE RESEARCH, 2002, 11 (03) : 207 - 221
  • [5] Cella D, 2004, MANUAL FUNCTIONAL AS
  • [6] THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE
    CELLA, DF
    TULSKY, DS
    GRAY, G
    SARAFIAN, B
    LINN, E
    BONOMI, A
    SILBERMAN, M
    YELLEN, SB
    WINICOUR, P
    BRANNON, J
    ECKBERG, K
    LLOYD, S
    PURL, S
    BLENDOWSKI, C
    GOODMAN, M
    BARNICLE, M
    STEWART, I
    MCHALE, M
    BONOMI, P
    KAPLAN, E
    TAYLOR, S
    THOMAS, CR
    HARRIS, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) : 570 - 579
  • [7] Interpretation of changes in health-related quality of life - The remarkable universality of half a standard deviation
    Norman, GR
    Sloan, JA
    Wyrwich, KW
    [J]. MEDICAL CARE, 2003, 41 (05) : 582 - 592
  • [8] Validity and reliability of the FACT-G scale for use in the older person with cancer
    Overcash, J
    Extermann, M
    Parr, J
    Perry, J
    Balducci, L
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (06): : 591 - 596
  • [9] Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials
    Sloan, J
    Symonds, T
    Vargas-Chanes, D
    Fridley, B
    [J]. DRUG INFORMATION JOURNAL, 2003, 37 (01): : 23 - 31
  • [10] *SURV EP END RES, 2004, SEER STAT DAT INC SE